Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price ...
GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
New York Post on MSN2d
FDA proposes ending use of popular decongestant in cold medicinesThe US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Phenylephrine:CVS pulls cold medicines with the ingredient Companies such as Procter & Gamble and GSK were among several accused ... or remove such drugs from the market. The Consumer Healthcare ...
Koehler succeeds Ranndy Kellogg, takes the helm of the U.S. and Canada's leading brand of personal heart health products and ...
MENAP-SCI (Middle East, North Africa, and Pakistan Self Care Industry), a leading non-profit organization dedicated to ...
The Nigerian economy has seen the closure of many companies, especially multinational firms, which threw many Nigerians into ...
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
Global stock markets hold their breath as a neck-and-neck US election race leaves the future uncertain. I'm not taking any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback